Q² Solutions Expands Vaccines Business Development Coverage in Europe
By Default Author
By Default Author
Driving operational improvements and quality of our services
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
DownloadOur commitment to customer success is embedded in every facet of our operations.
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
Driving operational improvements and quality of our services
Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search jobsWe are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
DownloadOur labs bring expertise in protein production, antibody discovery, and immunogenicity to help you select the most promising candidates and reduce risk as you move toward IND-enabling studies.
a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.
Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider.
One of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies worldwide.
We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development. Our industry-leading team advances research by delivering scientific insights that help clients maximize the value of their data.
Combining cutting-edge technology platforms and state-of-the-art laboratories with over 35 years of clinical vaccine development.
We have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. We’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.
By Default Author
Morrisville, N.C. – February 12, 2020 – Q2 Solutions, a leading clinical trial laboratory services organization, is pleased to announce the addition of business development resources in support of their vaccine clinical trial laboratory services in the Europe, Middle East, and Africa (EMEA) region.
Q2 Solutions welcomes Joanna Zmurko, Senior Executive, Customer Solutions, who will be covering the EMEA region for their vaccine services. Joanna joins Q2 Solutions from Merck KGaA where she served as an R&D Virology Scientist as well as an Account Manager. Prior to Merck KGaA, Joanna was a Marie Curie Research Fellow at Katholieke Universiteit Leuven in Belgium, focusing on flaviviruses such as dengue and Zika.
“We are very excited to have a colleague with Joanna’s depth of skill and knowledge join our team. She is a pivotal addition to our team as we drive our global strategy forward, specifically focusing on expanding our penetration in the EMEA market”, said Kevin Jones, Q2 Solutions General Manager, Bioanalytical/ADME and Vaccines Laboratories. "Vaccine development is a key area of growth in the industry today and this addition of business development coverage aligns with our Vaccine growth strategy, as we further evolve and invest to service our customers and their needs across the globe.”
Visit www.q2labsolutions.com/vaccines to learn more about Q2 Solutions clinical trial vaccine laboratory services.
About Q2 Solutions
Q2 Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q2 Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q2 Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.
By Default Author